Share
𝕏 Facebook LinkedIn

A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.

AI: Melanie Research RF Safe Research Library Jan 1, 2025 NEUTRAL LOW

This translational engineering paper describes a portable RF birdcage/meander line antenna concept for repeated electromagnetic field stimulation at 64 MHz aimed at lowering amyloid-beta in Alzheimer’s disease. The abstract reports prior in vitro findings in primary human brain cultures showing reduced secreted Aβ-42 and Aβ-40 after 1 hour/day exposures for 14 days at SAR around 0.6 W/kg without observed toxicity. The current work focuses on simulated device design to achieve homogeneous SAR of 0.4–0.9 W/kg across brain memory regions with modeled temperature rise under 0.5°C, with phantom validation and clinical trials planned.

Key points

  • The stated therapeutic target is reduction of toxic amyloid-beta levels in Alzheimer’s disease using repeated RF stimulation.
  • In vitro PHB cultures reportedly showed reduced secreted Aβ-42 and Aβ-40 after 64 MHz exposure at SAR ~0.6 W/kg for 1 hour daily over 14 days, with no evidence of toxicity mentioned.
  • The engineering work uses ANSYS HFSS simulations to design a portable flexible birdcage antenna integrating sixteen meander line antennas.
  • The intended SAR range for the device is 0.4–0.9 W/kg with homogeneous deposition across brain memory areas in numerical models.
  • Thermal modeling in the abstract indicates a maximum temperature increase of less than 0.5°C over one hour of exposure.
  • Physical phantom validation and subsequent FDA-related steps and clinical trials are described as future phases.

Referenced studies & papers

Source: Open original

AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.